|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00512 GRAND PHARMA
Nominal 
4.740 0.000 (0.000%) | 2024/06 - Interim HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | -- | 2,424,895 | 1,842,676 | 2,005,675 | 1,455,946 |
| Net Cash from / (used in) Investing Activities | -- | (515,747) | (2,360,106) | (1,768,979) | (1,513,163) |
| Net Cash from / (used in) Financing Activities | -- | (1,889,399) | 327,000 | (333,171) | 774,269 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 19,749 | (190,430) | (96,475) | 717,052 |
| Cash & Cash Equivalents at beginning of period | -- | 1,444,014 | 1,752,860 | 1,836,695 | 1,059,269 |
| Effect of Foreign Exchange Rate Changes | -- | (124,055) | (118,416) | 12,640 | 60,374 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,339,708 | 1,444,014 | 1,752,860 | 1,836,695 |
| Remarks: | Real time quote last updated: 15/11/2024 08:52 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 1,557,945 |
| %Change | 51.352% |
| EPS / (LPS) | HKD 0.444 |
| NBV Per Share ($) | HKD 4.428 |